BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18332125)

  • 1. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression.
    Chang CJ; Mulholland DJ; Valamehr B; Mosessian S; Sellers WR; Wu H
    Mol Cell Biol; 2008 May; 28(10):3281-9. PubMed ID: 18332125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
    Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
    FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Tumor Cell Lactate-generating Signaling Pathways Eradicates Murine PTEN/p53-deficient Aggressive-variant Prostate Cancer via Macrophage Phagocytosis.
    Chaudagar K; Hieromnimon HM; Kelley A; Labadie B; Shafran J; Rameshbabu S; Drovetsky C; Bynoe K; Solanki A; Markiewicz E; Fan X; Loda M; Patnaik A
    Clin Cancer Res; 2023 Dec; 29(23):4930-4940. PubMed ID: 37721526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.
    Muniyan S; Ingersoll MA; Batra SK; Lin MF
    Biochim Biophys Acta; 2014 Aug; 1846(1):88-98. PubMed ID: 24747769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells.
    Naguib A; Mathew G; Reczek CR; Watrud K; Ambrico A; Herzka T; Salas IC; Lee MF; El-Amine N; Zheng W; Di Francesco ME; Marszalek JR; Pappin DJ; Chandel NS; Trotman LC
    Cell Rep; 2018 Apr; 23(1):58-67. PubMed ID: 29617673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA and phosphoprotein profiles of TP53- and PTEN-knockouts in MCF10A at baseline and responding to DNA damage.
    Lin C; Schoenherr RM; Voytovich UJ; Ivey RG; Kennedy JJ; Whiteaker JR; Wang P; Paulovich AG
    Sci Data; 2024 Jan; 11(1):27. PubMed ID: 38177134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of endurance training with and without vitamin E on expression of p53 and PTEN tumor suppressing genes in prostate glands of male rats.
    Dashtiyan AA; Sepehrimanesh M; Tanideh N; Afzalpour ME
    Biochim Open; 2017 Jun; 4():112-118. PubMed ID: 29450148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.
    Bassi C; Ho J; Srikumar T; Dowling RJ; Gorrini C; Miller SJ; Mak TW; Neel BG; Raught B; Stambolic V
    Science; 2013 Jul; 341(6144):395-9. PubMed ID: 23888040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN: Multiple Functions in Human Malignant Tumors.
    Milella M; Falcone I; Conciatori F; Cesta Incani U; Del Curatolo A; Inzerilli N; Nuzzo CM; Vaccaro V; Vari S; Cognetti F; Ciuffreda L
    Front Oncol; 2015; 5():24. PubMed ID: 25763354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin PTEN is involved in DNA damage response partly through regulating Rad52 sumoylation.
    Choi BH; Chen Y; Dai W
    Cell Cycle; 2013 Nov; 12(21):3442-7. PubMed ID: 24047694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative Stress-Mediated RUNX3 Mislocalization Occurs Via Jun Activation Domain-Binding Protein 1 and Histone Modification.
    Kang KA; Piao MJ; Fernando PDSM; Herath HMUL; Boo HJ; Yoon SP; Hyun JW
    Appl Biochem Biotechnol; 2024 Apr; ():. PubMed ID: 38683453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome.
    Yavuz BR; Arici MK; Demirel HC; Tsai CJ; Jang H; Nussinov R; Tuncbag N
    NPJ Genom Med; 2023 Nov; 8(1):37. PubMed ID: 37925498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous PTEN acts as the key determinant for mTOR inhibitor sensitivity by inducing the stress-sensitized PTEN-mediated death axis in KSHV-associated malignant cells.
    Das P; Pal S; Das N; Chakraborty K; Chatterjee K; Mal S; Choudhuri T
    Front Mol Biosci; 2023; 10():1062462. PubMed ID: 37602330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMSC-exosomes miR-25-3p Regulates the p53 Signaling Pathway Through PTEN to Inhibit Cell Apoptosis and Ameliorate Liver Ischemia‒reperfusion Injury.
    Li H; Lin W; Zhang G; Liu R; Qu M; Zhang J; Xing X
    Stem Cell Rev Rep; 2023 Nov; 19(8):2820-2836. PubMed ID: 37594613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 and microRNA-148a affects PTEN, NO and ROS in canine leishmaniasis.
    De Freitas JH; Bragato JP; Rebech GT; Costa SF; Dos Santos MO; Soares MF; Eugênio FR; Dos Santos PSP; De Lima VMF
    Front Genet; 2023; 14():1106496. PubMed ID: 37124626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear PTEN's Functions in Suppressing Tumorigenesis: Implications for Rare Cancers.
    Langdon CG
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830628
    [No Abstract]   [Full Text] [Related]  

  • 17. Exosome-based strategies for diagnosis and therapy of glioma cancer.
    Karami Fath M; Azami J; Masoudi A; Mosaddeghi Heris R; Rahmani E; Alavi F; Alagheband Bahrami A; Payandeh Z; Khalesi B; Dadkhah M; Pourzardosht N; Tarhriz V
    Cancer Cell Int; 2022 Aug; 22(1):262. PubMed ID: 35989351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear PTEN deficiency and heterozygous PTEN loss have distinct impacts on brain and lymph node size.
    Igarashi A; Kato T; Sesaki H; Iijima M
    Biochem Biophys Res Commun; 2021 May; 555():81-88. PubMed ID: 33813280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP4 augments the survival of hepatocellular carcinoma (HCC) cells under hypoxia and hypoglycemia conditions by promoting the glycolysis pathway.
    Zhong J; Kang Q; Cao Y; He B; Zhao P; Gou Y; Luo Y; He TC; Fan J
    Am J Cancer Res; 2021; 11(3):793-811. PubMed ID: 33791154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
    Day EK; Zhong Q; Purow B; Lazzara MJ
    Cancer Res; 2021 Apr; 81(8):2056-2070. PubMed ID: 33574084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.